The total sample included 5761 patients, 3216 (56%) with colorectal cancer and 2545 (44%) with lung cancer. Sixty-four percent of the sample was white, 14% was black, 7% was Hispanic/Latino, 6% API, and 3% reported being multiracial. Sample characteristics are further reported in Table 1.